Twitter | Search | |
This is the legacy version of twitter.com. We will be shutting it down on 15 December 2020. Please switch to a supported browser or device. You can see a list of supported browsers in our Help Center.
IPATH
The first center in North America using therapy to combat infections
97
Tweets
336
Following
1,644
Followers
Tweets
IPATH Oct 6
We are happy to announce that we have hired two new postdoctoral fellows in the Pride Lab! We received a large number of qualified applicants for these positions, and we want to thank everyone who took the time to apply and show interest in working with IPATH.
Reply Retweet Like
IPATH retweeted
Saima Aslam Aug 27
1. Excited to share details of compassionate use cases at and lessons learnt from our 10 cases.
Reply Retweet Like
IPATH Aug 25
We're hiring! The Pride lab is looking for two qualified postdoctoral fellows that are interested in working with . Interested applicants find more information at the below link:
Reply Retweet Like
IPATH retweeted
Hedieh Attai Aug 6
Hey, phage phriends! The Pride lab is hiring a new postdoc! Learn more about what we do: and DM me for more info! 🦠🧫🔬🧪
Reply Retweet Like
IPATH Aug 3
We have 11 days left of our crowdfunding event!! By donating, you can help us save more patients from superbug infections!
Reply Retweet Like
IPATH retweeted
UC San Diego School of Medicine Jul 29
Features and their work using to treat bacterial infections associated with
Reply Retweet Like
IPATH Jul 20
We recently received funding to build out a new bank! If you want to be a part of this exciting movement, you can donate now to our NEW crowdsurf site!
Reply Retweet Like
IPATH Jul 6
Catch up with by reading our July Quarterly Newsletter, where we discuss 's new grant and the reopening of our phage lab!
Reply Retweet Like
IPATH Apr 20
Check out 's April Newsletter (COVID-19 Edition) that discusses how IPATH faculty and fellow researchers are doing their part in the fight against .
Reply Retweet Like
IPATH Mar 12
IPATH’s Pride Lab is looking for talented & curious undergraduates to volunteer this summer on our hunt for phages against superbugs! Check out our website to learn more about our lab:
Reply Retweet Like
IPATH retweeted
Steffanie Strathdee, PhD 🗡️ 🦠Superbug Slayer🗡️ Feb 27
Here's the commentary & I co-authored that discusses our views on how should be treated in .
Reply Retweet Like
IPATH Feb 26
Come join us for seminar today! We’re excited to welcome at UCSD in Leichtag 107 at 3 pm. 🦠🧬
Reply Retweet Like
IPATH retweeted
Jeremy J Barr Feb 11
Dear Phage phriends! We are hosting a Bacteriophage Symposium here in Melbourne, Australia on the 30th of March this year! Talks from UCSD, and speakers from across Australia. Please share and we'd love for you to attend if possible. Register here:
Reply Retweet Like
IPATH retweeted
Steffanie Strathdee, PhD 🗡️ 🦠Superbug Slayer🗡️ Jan 29
Awesome to welcome ⁦⁩ to ⁦⁩ by ⁦⁩ & to talk about his awesome research on filamentous & !
Reply Retweet Like
IPATH Jan 28
Join us for seminar tomorrow at with this month’s speaker, !
Reply Retweet Like
IPATH retweeted
Grace Kovalick 17 Nov 19
Launching the phage latern into 2020 a little early...🦠🎉
Reply Retweet Like
IPATH retweeted
UC San Diego School of Medicine 13 Nov 19
This is the first time phage therapy has been applied (in mice) to a condition that's not a classic bacterial infection
Reply Retweet Like
IPATH 3 Oct 19
We are excited to roll out the first Quarterly Newsletter! Some highlights include: recent funding announcements, an interview with with 's postdoc , and a publication spotlight on .
Reply Retweet Like
IPATH 27 Aug 19
This month's IPATH seminar series welcomes from , who will present on the coevolution of Enterococcus phages from the human microbiome. The seminar takes place at San Diego State University tomorrow (8/28/19) at 3 PM.
Reply Retweet Like
IPATH retweeted
Steffanie Strathdee, PhD 🗡️ 🦠Superbug Slayer🗡️ 26 Mar 19
Proud that our non-profit, is working with & Canadian physicians to bring to to help patients with deadly infections who have run out of options.
Reply Retweet Like